EH64

ICD-11 MMS 2026-01

Drug-induced erythroderma

Description

Erythroderma (defined as erythema and scaling involving at least 90% of the skin surface) which is attributable to drug administration but which cannot be more precisely categorized, thus excluding more specific severe cutaneous adverse reactions to drugs reaction patterns such as DRESS syndrome, acute generalised exanthematous pustulosis (AGEP) and toxic epidermal necrolysis. Many drugs have been implicated.

Index terms

  • Drug-induced erythroderma
  • Drug-induced exfoliative dermatitis
  • Generalised exfoliative dermatitis due to drug

Excludes

  • EH63 – Stevens-Johnson syndrome or toxic epidermal necrolysis due to drug
  • EH63.1 – Drug-induced toxic epidermal necrolysis
  • EH63.2 – Drug-induced Stevens-Johnson and toxic epidermal necrolysis overlap syndrome
  • EH65 – DRESS syndrome
  • EH67.0 – Drug-induced acute generalised exanthematous pustulosis

Sibling codes

  • EH60 – Exanthematic drug eruption
  • EH61 – Drug-induced urticaria, angioedema or anaphylaxis
  • EH62 – Lichenoid drug eruption
  • EH63 – Stevens-Johnson syndrome or toxic epidermal necrolysis due to drug
  • EH65 – DRESS syndrome
  • EH66 – Fixed drug eruption
  • EH67 – Acne or acneiform reactions attributable to drugs
  • EH6Y – Drug eruption of other specified type
  • EH6Z – Drug eruption of unspecified type

Foundation entity

Drug-induced erythroderma – http://id.who.int/icd/entity/586101376

Allowed postcoordination axes

Part of: 14: Diseases of the skin